200wk Uptrend — rising+above (sma 55.32 vs px 131)
Funds Accumulating — momZ +3.10 · 1.95→2.25
Founder-Led — founder/CEO led
About Palvella Therapeutics, Inc
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformation… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: December 16, 2024
Headquarters: 353 W. Lancaster Avenue, Wayne, PA, United States, 19087
Founder-Led: Yes — Wes Kaupinen (Founder, President, CEO & Director)
Key Metrics
Current Price
$130.59
Market Cap
$1.91B
Float
10.7M
Shares Outstanding
14.4M
vs. Analyst Target
+76.5% to analyst PT
Dividend Rate
None
Analyst Target Price
$230.53 (15 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$29.3M
-$37.2M
$29.3M
-$34.9M
2021
$31.4M
-$45.7M
$29.1M
-$43.4M
2022
$25.9M
-$33.3M
$23.1M
-$30.5M
2023
N/A
$18.7M
N/A
$18.7M
2024
N/A
-$17.4M
N/A
-$13.1M
2025
N/A
-$41.7M
N/A
-$35.9M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
N/A
-$11.3M
Dec 2025
N/A
-$12.7M
Mar 2026
N/A
-$15.8M
Jun 2026
N/A
-$21.9M
Ownership & Float
Insider Ownership
11.6%
Institutional Ownership
103.8%
Short Float
21.5%
% of All Funds Holding
2.25%
Number of Funds Holding
198
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$146.51
Near-term / short-term trend
Weekly
40-Week SMA
$124.71
Medium-term trend
Weekly
80-Week SMA
$88.75
Cyclical trend (business cycle)
Weekly
200-Week SMA
$55.32
Secular trend (multi-year)
Monthly
10-Month SMA
$129.61
Near-term monthly trend
Monthly
20-Month SMA
$91.79
Medium-term monthly trend
Monthly
40-Month SMA
$53.95
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$111.00
support
1.31x
3 months ago
$80.00
support
1.96x
7 months ago
$64.00
support
1.71x
11 months ago
$36.70
support
1.55x
13 months ago
$22.60
support
2.46x
14 months ago
Historical Earnings Reactions (46 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.50%
0.27%
54.35%
17.39%
-5.21%
1 Day
2.34%
2.32%
67.39%
34.16%
-15.72%
1 Week
3.03%
2.22%
58.70%
95.83%
-26.72%
2 Weeks
4.08%
0.08%
50.00%
65.63%
-32.26%
1 Month
2.53%
-3.92%
44.44%
83.85%
-43.32%
Next earnings: November 10, 2026 (32 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
6.9%
63.6%
11
Feb
9.5%
58.3%
12
Mar
0.3%
41.7%
12
Apr
-7.1%
25.0%
12
May
13.7%
50.0%
12
Jun
-5.9%
41.7%
12
Jul
14.8%
66.7%
12
Aug
11.6%
66.7%
12
Sep
-9.1%
33.3%
12
Oct
-5.0%
27.3%
11
Nov
6.7%
54.5%
11
Dec
-5.1%
36.4%
11
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.07%
48.3%
553
Tuesday
0.35%
42.7%
609
Wednesday
0.15%
46.7%
606
Thursday
-0.19%
41.6%
596
Friday
0.28%
48.6%
591
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 103.8%
Insider Transactions — Smart Summary
Total insider ownership: 11.6%
Founder-led management: Wes Kaupinen (Founder, President, CEO & Director)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Palvella Therapeutics, Inc
(PVLA) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.